Assessment of the MSF triage system, separating patients into different wards pending ebola virus laboratory confirmation, Kailahun, Sierra Leone, July to September 2014

Eurosurveillance

Volumn 20, Issue 50, 2015, Pages

  Vogt, Florian ^a   Fitzpatrick, G ^b   Patten, G ^b   van den Bergh, R ^a   Stinson, K ^b   Pandolfi, L ^b   Squire, J ^c   Decroo, T ^a   Declerck, H ^a   Van Herp, M ^a  

^a MÉDECINS SANS FRONTIÈRES   (Belgium)

^b MÉDECINS SANS FRONTIÈRES   (Switzerland)

^c Ministry of Health and Sanitation   (Sierra Leone)

Author keywords

[No Author keywords available]

Indexed keywords

BIOSAFETY; DIAGNOSTIC TEST ACCURACY STUDY; EBOLAVIRUS; EMERGENCY HEALTH SERVICE; EXPOSURE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; PATIENT CODING; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; SIERRA LEONE; STATISTICS; TURNAROUND TIME; ADOLESCENT; ADULT; CROSS INFECTION; DISEASE OUTBREAKS; FEMALE; GENETICS; HEMORRHAGIC FEVER, EBOLA; HOSPITALIZATION; MALE; ORGANIZATION AND MANAGEMENT; PATHOGENICITY; POINT OF CARE SYSTEM; PROGRAM EVALUATION; STATISTICS AND NUMERICAL DATA; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; CROSS INFECTION; DISEASE OUTBREAKS; EBOLAVIRUS; FEMALE; HEMORRHAGIC FEVER, EBOLA; HOSPITALIZATION; HUMANS; MALE; POINT-OF-CARE SYSTEMS; PROGRAM EVALUATION; SIERRA LEONE; TRIAGE; YOUNG ADULT;

EID: 84973411649     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES.2015.20.50.30097     Document Type: Article

References (39)

1. Farrar JJ, Piot P. The Ebola emergency--immediate action, ongoing strategy. N Engl J Med. 2014;371(16):1545-6. DOI: 10.1056/NEJMe1411471 PMID: 25244185
2. World Health Organization (WHO). Ebola virus disease in Guinea. Geneva: WHO; 23 March 2014. Available from: http://www.afro.who.int/en/clusters-a-programmes/dpc/epidemica-pandemic-alert-and-response/outbreak-news/4063-ebolahemorrhagic-fever-in-guinea.html
3. Weyer J, Blumberg LH, Paweska JT. Ebola virus disease in West Africa - an unprecedented outbreak. S Afr Med J. 2014;104(8):555-6. DOI: 10.7196/samj.8672 PMID: 25213844
4. World Health Organization (WHO). Statement on the 1st meeting of the IHR Emergency Committee on the 2014 Ebola outbreak in West Africa. Geneva: WHO; 8 August 2014. Available from: http://who.int/mediacentre/news/statements/2014/ebola-20140808/en/
5. Médecins Sans Frontières. Sierra Leone: Ebola cases expected to increase; 11 July 2014. Available from: http://www.msf.org.uk/article/sierra-leone-ebola-cases-expected-increase
6. Dowell SF, Mukunu R, Ksiazek TG, Khan AS, Rollin PE, Peters CJ. Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis. 1999;179(s1) Suppl 1;S87-91. DOI: 10.1086/514284 PMID: 9988169
7. Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet. 2011;377(9768):849-62. DOI: 10.1016/S0140-6736(10)60667-8 PMID: 21084112
8. Peters CJ, LeDuc JW. An introduction to Ebola: the virus and the disease. J Infect Dis. 1999;179(s1) Suppl 1;9-16. DOI: 10.1086/514322 PMID: 9988154
9. Ksiazek TG, Rollin PE, Williams AJ, Bressler DS, Martin ML, Swanepoel R, et al. Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis. 1999;179(s1) Suppl 1;S177-87. DOI: 10.1086/514321 PMID: 9988182
10. Legrand J, Grais RF, Boelle PY, Valleron AJ, Flahault A. Understanding the dynamics of Ebola epidemics. Epidemiol Infect. 2007;135(4):610-21. DOI: 10.1017/S0950268806007217 PMID: 16999875
11. Chowell G, Hengartner NW, Castillo-Chavez C, Fenimore PW, Hyman JM. The basic reproductive number of Ebola and the effects of public health measures: the cases of Congo and Uganda. J Theor Biol. 2004;229(1):119-26. DOI: 10.1016/j.jtbi.2004.03.006 PMID: 15178190
12. Towner JS, Sealy TK, Ksiazek TG, Nichol ST. High-throughput molecular detection of hemorrhagic fever virus threats with applications for outbreak settings.J Infect Dis. 2007;196(s2) Suppl 2;S205-12. DOI: 10.1086/520601 PMID: 17940951
13. Borchert M, Mutyaba I, Van Kerkhove MD, Lutwama J, Luwaga H, Bisoborwa G, et al. Ebola haemorrhagic fever outbreak in Masindi District, Uganda: outbreak description and lessons learned. BMC Infect Dis. 2011;11(1):357. DOI: 10.1186/1471-2334-11-357 PMID: 22204600
14. Roddy P, Colebunders R, Jeffs B, Palma PP, Van Herp M, Borchert M. Filovirus hemorrhagic fever outbreak case management: a review of current and future treatment options. J Infect Dis. 2011;204(Suppl 3):S791-5. DOI: 10.1093/infdis/jir297 PMID: 21987752
15. World Health Organization (WHO). Case definition recommendations for Ebola or Marburg Virus Diseases. Geneva: WHO; 9 August 2014. Available from: http://www.who.int/csr/resources/publications/ebola/ebola-case-definitioncontact-en.pdf?ua=1
16. European Centre for Disease Prevention and Control (ECDC). Ebola virus disease case definition for reporting in EU. Stockholm: ECDC. [Accessed 16 Dec 2015]. Available from: http://ecdc.europa.eu/en/healthtopics/ebola_marburg_fevers/EVDcasedefinition/Pages/default.aspx
17. Center for Disease Control and Prevention (CDC). Case Definition for Ebola Virus Disease (EVD). Atlanta: CDC; 16 November 2014. Available from: http://www.cdc.gov/vhf/ebola/hcp/case-definition.html
18. Fitzpatrick G, Vogt F, Moi Gbabai O, Black B, Santantonio M, Folkesson E, et al. Describing readmissions to an Ebola case management centre (CMC), Sierra Leone, 2014. Euro Surveill. 2014;19(40):20924. DOI: 10.2807/1560-7917. ES2014.19.40.20924 PMID: 25323075
19. Fisher-Hoch SP. Lessons from nosocomial viral haemorrhagic fever outbreaks. Br Med Bull. 2005;73-74(1):123-37. DOI: 10.1093/bmb/ldh054 PMID: 16373655
20. World Health Organization (WHO). Interim Infection Prevention and Control Guidance for Care of Patients with Suspected or Confirmed Filovirus Haemorrhagic Fever in Health-Care Settings, with Focus on Ebola. Geneva: WHO; December 2014. Available from: http://apps.who.int/iris/bitstream/10665/130596/1/WHO_HIS_SDS_2014.4_eng.pdf?ua=1&ua=1&ua=1
21. Towner JS, Rollin PE, Bausch DG, Sanchez A, Crary SM, Vincent M, et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol. 2004;78(8):4330-41. DOI: 10.1128/JVI.78.8.4330-4341.2004 PMID: 15047846
22. Center for Disease Control and Prevention (CDC). Guidance for Collection, Transport, and Submission of Specimens for Ebola Virus Testing in the United States. Atlanta: CDC; 30 January 2015. Available from: http://www.cdc.gov/vhf/ebola/pdf/ebola-lab-guidance.pdf
23. Drazen JM, Kanapathipillai R, Campion EW, Rubin EJ, Hammer SM, Morrissey S, et al. Ebola and quarantine. N Engl J Med. 2014;371(21):2029-30. DOI: 10.1056/NEJMe1413139 PMID: 25347231
24. Sterk E. Filovirus Haemorrhagic Fever Guideline. Médecins Sans Frontières; 2008. Available from: www.medbox.org/filovirus-haemorrhagic-fever-guideline/download.pdf
25. Statistics Sierra Leone. 2004 Population And Housing Census – Final Results; 2004. Available from: http://www.sierra-leone.org/Census/ssl_final_results.pdf
26. Gire SK, Goba A, Andersen KG, Sealfon RS, Park DJ, Kanneh L, et al. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science. 2014;345(6202):1369-72. DOI: 10.1126/science.1259657 PMID: 25214632
27. Washington Post. The birthplace of an outbreak; 28 August 2014. Available from: http://www.washingtonpost.com/sf/style/2014/08/28/ebola-outbreak/
28. Wolz A. Face to face with Ebola--an emergency care center in Sierra Leone. N Engl J Med. 2014;371(12):1081-3. DOI: 10.1056/NEJMp1410179 PMID: 25162580
29. de La Vega MA, Caleo G, Audet J, Qiu X, Kozak RA, Brooks JI, et al. Ebola viral load at diagnosis associates with patient outcome and outbreak evolution. J Clin Invest. 2015;125(12):4421-8. DOI: 10.1172/JCI83162 PMID: 26551677
30. Altman DG, Bland JM. Statistics Notes: Diagnostic tests 2: Predictive values. BMJ. 1994;309(6947):102. DOI: 10.1136/bmj.309.6947.102 PMID: 8038641
31. Bah EI, Lamah MC, Fletcher T, Jacob ST, Brett-Major DM, Sall AA, et al. Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. N Engl J Med. 2015;372(1):40-7. DOI: 10.1056/NEJMoa1411249 PMID: 25372658
32. Centers for Disease Control and Prevention (CDC), Nyenswah T, Fahnbulleh M, Massaquoi M, Nagbe T, Bawo L, Falla JD, et al. Ebola epidemic--Liberia, March-October 2014.MMWR Morb Mortal Wkly Rep. 2014;63(46):1082-6. PMID: 25412068
33. Kelly JD. Make diagnostic centres a priority for Ebola crisis. Nature. 2014;513(7517):145. DOI: 10.1038/513145a PMID: 25209763
34. World Health Organization (WHO). Urgently needed: rapid, sensitive, safe and simple Ebola diagnostic tests. Geneva: WHO; 18 November 2014. Available from: http://www.who.int/mediacentre/news/ebola/18-november-2014-diagnostics/en/
35. Broadhurst MJ, Kelly JD, Miller A, Semper A, Bailey D, Groppelli E, et al. ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study. Lancet. 2015;386(9996):867-74. DOI: 10.1016/S0140-6736(15)61042-X PMID: 26119838
36. World Health Organization (WHO). Emergency Use Assessment and Listing for Ebola Virus Disease IVDs – Product: ReEBOV™ Antigen Rapid Test Kit EUAL. Geneva: WHO; June 2015. Available from: http://www.who.int/diagnostics_laboratory/procurement/150219_reebov_antigen_rapid_test_public_report.pdf?ua=1
37. Trust W. New 15-minute test for Ebola to be trialled in Guinea; 28 November 2014. Available from: http://www.wellcome.ac.uk/News/Media-office/Press-releases/2014/WTP058046.htm
38. World Health Organization. Emergency Use Assessment and Listing for EVD IVDs – Product: Xpert® Ebola Assay; May 2015. Available from: http://www.who.int/medicines/ebola-treatment/150508FinalPublicReportExpertEbola_Cepheid.pdf
39. Strecker T, Palyi B, Ellerbrok H, Jonckheere S, de Clerck H, Bore JA, et al. Field Evaluation of Capillary Blood Samples as a Collection Specimen for the Rapid Diagnosis of Ebola Virus Infection During an Outbreak Emergency. Clin Infect Dis. 2015;61(5):669-75. DOI: 10.1093/cid/civ397 PMID: 25991465